VAGHI, GLORIA
 Distribuzione geografica
Continente #
NA - Nord America 138
EU - Europa 101
AS - Asia 27
Totale 266
Nazione #
US - Stati Uniti d'America 138
IE - Irlanda 62
CN - Cina 21
IT - Italia 16
FI - Finlandia 11
DE - Germania 8
JP - Giappone 4
AT - Austria 1
CZ - Repubblica Ceca 1
IN - India 1
LU - Lussemburgo 1
NL - Olanda 1
TH - Thailandia 1
Totale 266
Città #
Dublin 62
Chandler 51
Ashburn 13
Helsinki 11
Shanghai 10
Lawrence 6
Medford 6
New York 6
Princeton 6
Boardman 5
Los Angeles 4
Tokyo 4
Piscataway 3
Seveso 3
Wilmington 3
Beijing 2
Torino 2
Amsterdam 1
Bangkok 1
Brno 1
Castegnato 1
Fayetteville 1
Germantown 1
Luxembourg 1
Marghera 1
Norwalk 1
Pune 1
Rome 1
Seattle 1
Shijiazhuang 1
Vienna 1
Woodbridge 1
Xi'an 1
Totale 213
Nome #
Correlation of frontal atrophy and CSF tau levels with neuropsychiatric symptoms in patients with cognitive impairment: a memory clinic experience 58
Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study 36
COVID-19 in patients with Myasthenia Gravis: epidemiology and disease course 32
BEHAVIORAL and PSYCHOLOGICAL SYMPTOMS in the CLINICAL PICTURE of DEMENTIA 32
Expression of selected microRNAs in migraine: A new class of possible biomarkers of disease? 29
Correction to: Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study (The Journal of Headache and Pain, (2021), 22, 1, (114), 10.1186/s10194-021-01333-4) 29
Potential Contribution of Hypertension to Evolution of Chronic Migraine and Related Mechanisms 28
Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial 20
Peripheral Endocannabinoid Components and Lipid Plasma Levels in Patients with Resistant Migraine and Co-Morbid Personality and Psychological Disorders: A Cross-Sectional Study 9
Arterial hypertension in the chronic evolution of migraine: bystander or risk factor? An overview 6
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 5
Who cares about migraine? Pathways and hurdles in the European region - access to care III 2
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study 2
Totale 288
Categoria #
all - tutte 1.503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.503


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 0 0 0 12 6 1 0 2
2021/202221 0 0 0 0 0 0 0 3 1 3 1 13
2022/2023151 13 11 0 10 13 11 2 13 68 3 6 1
2023/202494 7 10 2 1 8 12 2 15 1 6 14 16
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 288